UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
UMB Financial
UMBF
$11B
| $1.06M | ﹤0.01% |
18,666
+1,567
| +9% | +$84.2K |
|
1602
Entegris
ENTG
$21.8B
| $1.06M | ﹤0.01% |
72,795
+9,600
| +15% | +$135K |
|
|
OUTR
1603
DELISTED
OUTERWALL INC
OUTR
| $1.06M | ﹤0.01% |
13,889
+200
| +1% | +$14.6K |
|
1604
Spire
SR
$4.78B
| $1.05M | ﹤0.01% |
20,199
+2,200
| +12% | +$115K |
|
1605
Benchmark Electronics
BHE
$2.96B
| $1.05M | ﹤0.01% |
48,198
+4,500
| +10% | +$107K |
|
1606
Unitil
UTL
$981M
| $1.05M | ﹤0.01% |
31,794
+874
| +3% | +$29.5K |
|
|
SWFT
1607
DELISTED
Swift Transportation Company
SWFT
| $1.04M | ﹤0.01% |
45,997
+10,000
| +28% | +$246K |
|
|
NAV
1608
DELISTED
Navistar International
NAV
| $1.04M | ﹤0.01% |
46,041
-2,991
| -6% | -$81.8K |
|
1609
Texas Roadhouse
TXRH
$13.7B
| $1.04M | ﹤0.01% |
27,805
+1,600
| +6% | +$57.1K |
|
1610
CVB Financial
CVBF
$4B
| $1.04M | ﹤0.01% |
58,896
+8,000
| +16% | +$132K |
|
|
TPH
1611
DELISTED
Tri Pointe Homes
TPH
| $1.04M | ﹤0.01% |
67,731
+6,900
| +11% | +$103K |
|
1612
Cimpress
CMPR
$2.34B
| $1.03M | ﹤0.01% |
12,299
+1,000
| +9% | +$85.4K |
|
|
LTRPA
1613
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.03M | ﹤0.01% |
32,024
-8,806
| -22% | -$267K |
|
|
EEQ
1614
DELISTED
Enbridge Energy Management Llc
EEQ
| $1.03M | ﹤0.01% |
43,764
+2,533
| +6% | +$64.7K |
|
1615
First Financial Bankshares
FFIN
$4.97B
| $1.03M | ﹤0.01% |
59,292
+5,600
| +10% | +$85.4K |
|
1616
B2Gold
BTG
$5.45B
| $1.02M | ﹤0.01% |
670,563
+23,550
| +4% | +$38.2K |
|
|
KW
1617
DELISTED
Kennedy-Wilson Holdings
KW
| $1.02M | ﹤0.01% |
41,598
+5,300
| +15% | +$136K |
|
|
CLVS
1618
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.02M | ﹤0.01% |
11,600
+3,000
| +35% | +$257K |
|
1619
HNI Corp
HNI
$3.53B
| $1.02M | ﹤0.01% |
19,899
+2,000
| +11% | +$103K |
|
1620
CONMED
CNMD
$1.49B
| $1.01M | ﹤0.01% |
17,399
+1,700
| +11% | +$91.7K |
|
1621
Monolithic Power Systems
MPWR
$66.8B
| $1.01M | ﹤0.01% |
19,989
+1,700
| +9% | +$90K |
|
1622
Alamos Gold
AGI
$13B
| $1.01M | ﹤0.01% |
178,710
+5,000
| +3% | +$32.3K |
|
|
HAWK
1623
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.01M | ﹤0.01% |
24,570
+9,141
| +59% | +$341K |
|
1624
MKS Inc
MKSI
$19.7B
| $1.01M | ﹤0.01% |
26,598
+2,300
| +9% | +$83.8K |
|
|
ADVS
1625
DELISTED
Advent Software Inc
ADVS
| $1.01M | ﹤0.01% |
22,799
+1,100
| +5% | +$48.1K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.